Definium Therapeutics Inc. Common Shares vs iShares MSCI Taiwan ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.4 (market cap $4.59B), while iShares MSCI Taiwan ETF trades at $114.66 (market cap $12.74B). The key difference: iShares MSCI Taiwan ETF is far larger — about 2.8× Definium Therapeutics Inc. Common Shares's market cap, and iShares MSCI Taiwan ETF is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and iShares MSCI Taiwan ETF for 52 Days on average.
| DFTX | EWT | |
|---|---|---|
Market Cap | $4.59B | $12.74B |
Volume | 2,103,937 | 8,470,920 |
Sector | Health | Broad Market / Factor |
52-Week High | $48.45 | $118.00 |
52-Week Low | $10.68 | $60.03 |
Typical Hold Time | 0 Days | 52 Days |
Enterprise Value | $3.55B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EWT, the iShares MSCI Taiwan ETF, trades at $116.24, down 1.16% on the day, with a bullish technical signal from moving averages and neutral oscillators. The ETF is heavily concentrated in Taiwan's semiconductor sector, particularly TSMC, benefiting from AI-driven demand. Recent news highlights strong institutional interest and substantial Taiwanese corporate investments in U.S. AI infrastructure, though geopolitical tensions with China present ongoing risks.
The outlook for EWT is positive due to Taiwan's pivotal role in AI and semiconductor supply chains, supported by robust capital expenditure plans from key holdings. However, elevated geopolitical risks and sector concentration require careful monitoring. Upside potential hinges on sustained AI demand, while downside risks include cross-strait tensions and global tech volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.
Read more on EWT →